1718 related articles for article (PubMed ID: 8299185)
1. [Lymphocytic infiltration in uveal melanoma].
Sach J; Kocur J
Cesk Oftalmol; 1993 Nov; 49(6):380-6. PubMed ID: 8299185
[TBL] [Abstract][Full Text] [Related]
2. Analysis of lymphocytic infiltration in uveal melanoma.
Durie FH; Campbell AM; Lee WR; Damato BE
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2106-10. PubMed ID: 2211008
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma.
Whelchel JC; Farah SE; McLean IW; Burnier MN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2603-6. PubMed ID: 8325762
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic role of morphological characteristics of the immune response in uveal melanoblastomas of various cellular types].
Vit VV
Arkh Patol; 1983; 45(7):25-30. PubMed ID: 6625934
[TBL] [Abstract][Full Text] [Related]
5. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression.
García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878
[TBL] [Abstract][Full Text] [Related]
6. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
7. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
[TBL] [Abstract][Full Text] [Related]
8. Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior?
Staibano S; Mascolo M; Tranfa F; Salvatore G; Mignogna C; Bufo P; Nugnes L; Bonavolontà G; De Rosa G
Int J Immunopathol Pharmacol; 2006; 19(1):171-9. PubMed ID: 16569355
[TBL] [Abstract][Full Text] [Related]
9. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
Nifontova TP
Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
Tóth-Molnár E; Hammer H; Oláh J
Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
[TBL] [Abstract][Full Text] [Related]
11. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.
Chen X; Maniotis AJ; Majumdar D; Pe'er J; Folberg R
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2533-9. PubMed ID: 12147581
[TBL] [Abstract][Full Text] [Related]
12. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA
Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
[TBL] [Abstract][Full Text] [Related]
15. Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes.
Hallermalm K; De Geer A; Kiessling R; Levitsky V; Levitskaya J
Cancer Res; 2004 Sep; 64(18):6775-82. PubMed ID: 15374996
[TBL] [Abstract][Full Text] [Related]
16. Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value.
Anastassiou G; Coupland SE; Stang A; Boeloeni R; Schilling H; Bornfeld N
J Pathol; 2001 Aug; 194(4):466-72. PubMed ID: 11523055
[TBL] [Abstract][Full Text] [Related]
17. MRI for the evaluation of scleral invasion and extrascleral extension of uveal melanomas.
Récsán Z; Karlinger K; Fodor M; Zalatnai A; Papp M; Salacz G
Clin Radiol; 2002 May; 57(5):371-6. PubMed ID: 12014934
[TBL] [Abstract][Full Text] [Related]
18. AgNOR values in Callender histopathological types of malignant uveal melanomas.
Mera M
Rom J Morphol Embryol; 1995; 41(3-4):125-8. PubMed ID: 8772368
[TBL] [Abstract][Full Text] [Related]
19. [Prospects for developing treatment of uveal melanoma from the position of modern carcinogenesis concepts].
Likhvantseva VG
Vestn Oftalmol; 2002; 118(1):32-5. PubMed ID: 11898358
[TBL] [Abstract][Full Text] [Related]
20. [Retrospective study of uveal melanoma].
Tóth J
Magy Onkol; 2005; 49(1):19-25. PubMed ID: 15902329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]